Showing 1 - 7 of 7
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005763258
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005763264
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181106
Objective: We estimate the effects of Reference Pricing, a drug cost control policy introduced by the BC Ministry of Health Pharmacare program in 1995, on its program expenditures for seniors, out of pocket costs paid by its senior beneficiaries, indicators of beneficiary health status and...
Persistent link: https://www.econbiz.de/10005181109
(see QSEP 369 for abstract)
Persistent link: https://www.econbiz.de/10005181110
(see SEDAP 70 for abstract)
Persistent link: https://www.econbiz.de/10005404416
OBJECTIVE: To estimate the effect of differential cost sharing (DCS) schemes for non-steroidal anti-inflammatory drugs (NSAIDs) on drug subsidy program and beneficiary expenditures. DATA SOURCES/STUDY SETTING: Monthly aggregate claims data from Pharmacare, the public drug subsidy program for...
Persistent link: https://www.econbiz.de/10005404447